BackBRAIN Biotech AG Overview

BRAIN Biotech AG Goodwill

BRAIN Biotech AG's goodwill is $0.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00

Peer trimmed avg / median

Loading

BRAIN Biotech AG Goodwill History

Loading

BRAIN Biotech AG vs. peers: Goodwill Comparison

Loading

BRAIN Biotech AG Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

BRAIN Biotech AG (BNN.DE) FAQ

BRAIN Biotech AG's goodwill stands at $0 as of June 2026. In the prior-year period, the figure was $0. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

BRAIN Biotech AG reported $0 in goodwill versus $0 a year earlier. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

In the prior-year period, the figure was $0. Sustained growth in goodwill can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how BRAIN Biotech AG's goodwill evolved across reporting periods, while the comparison chart places BNN.DE next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, goodwill is commonly used to spot outliers. BRAIN Biotech AG's reading of $0 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.